A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...

Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

“For whatever reasons men might choose to not proactively seek care, it is important to educate these men that there are modern screening methods for prostate cancer beyond the old methods,” Nix said.

Newer evidence from the POP-RT phase III trial did show that pelvic nodal radiation for high-risk, locally advanced prostate ...

La'Dale Robinson was living a full life as a single father, chef, and business owner when a routine checkup changed ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

For example, androgens attach to special receptors on the surface of prostate cancer cells, which enables the cells to send ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

In intermediate risk prostate cancer patients randomized to short-term ADT and either 70 Gy or 76 Gy, testosterone recovery ...